The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Thymol Inhibits Biofilm Formation, Eliminates Pre-Existing Biofilms, and Enhances Clearance of Methicillin-Resistant Staphylococcus aureus (MRSA) in a Mouse Peritoneal Implant Infection Model
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a common human pathogen that causes several difficult-to-treat infections, including biofilm-associated infections. The biofilm-forming ability of S. aureus plays a pivotal role in its resistance to most currently available antibiotics, including vancomycin, which is the first-choice drug for treating MRSA infections. In this study, the ability of thymol (a monoterpenoid phenol isolated from plants) to inhibit biofilm formation and to eliminate mature biofilms, was assessed. We found that thymol could inhibit biofilm formation and remove mature biofilms by inhibiting the production of polysaccharide intracellular adhesin (PIA) and the release of extracellular DNA (eDNA). However, cotreatment with thymol and vancomycin was more effective at eliminating MRSA biofilms, in a mouse infection model, than monotherapy with vancomycin. Comparative histopathological analyses revealed that thymol reduced the pathological changes and inflammatory responses in the wounds. Assessments of white blood cell counts and serum TNF-α and IL-6 levels showed reduced inflammation and an increased immune response following treatment with thymol and vancomycin. These results indicate that combinatorial treatment with thymol and vancomycin has the potential to serve as a more effective therapy for MRSA biofilm-associated infections than vancomycin monotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This component was reduced under the presence of THY and thus, bacteria could adhere to materials at the initial stage, but they were unable to form biofilms due to a reduced cell-tocell adhesion.54,56”
From Antimicrobial Wound Dressings against Fluorescent and Methicillin-Sensitive Intracellular Pathogenic Bacteria (2020) · cites this paper as [54]
In the citing paper
“In this sense, Yuan et al. also showed the efficiency of free THY in the inhibition of biofilm obtained from the non-clinical MRSA strain TCH1516 (ATCC BAA-1717).Biofilm formation and mature biofilm were inhibited by the treatment with up to 512 µg/mL of free THY, a concentration much higher than those released from our mats, though not achieving the complete eradication of bacteria growth.54”
From Antimicrobial Wound Dressings against Fluorescent and Methicillin-Sensitive Intracellular Pathogenic Bacteria (2020) · cites this paper as [54]
In the citing paper
“The effect of THY against bacterial adhesion has also been demonstrated by Yuan et al. 54 when they analyzed PIA (Polysaccharide Intracellular Adhesion), a component involved in adhesion and aggregation.”
From Antimicrobial Wound Dressings against Fluorescent and Methicillin-Sensitive Intracellular Pathogenic Bacteria (2020) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Research works printed but not linked: 66
- Lowy, 1998, Staphylococcus aureus infections, N. Engl. J. Med., 339, 520, 10.1056/NEJM199808203390806 · DOI · Paper page
- Foster, 2014, Adhesion, invasion, and evasion: The many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
- Amalaradjou, 2014, Antibiofilm effect of octenidine hydrochloride on Staphylococcus aureus, MRSA and VRSA, Pathogens, 3, 404, 10.3390/pathogens3020404 · doi:10.3390/pathogens3020404
- Rodvold, 2014, Methicillin-resistant Staphylococcus aureus therapy: Past, present, and future, Clin. Infect. Dis., 58, S20, 10.1093/cid/cit614 · DOI · Paper page
- Dryden, 2008, Complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: Epidemiology, risk factors, and presentation, Surg. Infect., 9, s3, 10.1089/sur.2008.066.supp · DOI
- Li, 2018, Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections, J. Orthop. Res., 36, 22, 10.1002/jor.23656 · DOI · Paper page
- Friedman, 2016, The negative impact of antibiotic resistance, Clin. Microbiol. Infect., 22, 416, 10.1016/j.cmi.2015.12.002 · DOI · Paper page
- Kiedrowski, 2011, New approaches for treating staphylococcal biofilm infections, Ann. N. Y. Acad. Sci., 1241, 104, 10.1111/j.1749-6632.2011.06281.x · DOI · Paper page
- Patel, 2007, The challenge of treating biofilm-associated bacterial infections, Clin. Pharm., 82, 204
- Mohammed, 2018, Vision for medicine: Staphylococcus aureus biofilm war and unlocking key’s for anti-biofilm drug development, Microb. Pathog., 123, 339, 10.1016/j.micpath.2018.07.002 · DOI
- Chung, 2014, Anti-biofilm agents: Recent breakthrough against multi-drug resistant Staphylococcus aureus, Pathog. Dis., 70, 231, 10.1111/2049-632X.12141 · DOI · Paper page
- Flemming, 2010, The biofilm matrix, Nat. Rev. Microbiol., 8, 623, 10.1038/nrmicro2415 · DOI · Paper page
- Pozzi, 2008, A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB, J. Bacteriol., 190, 3835, 10.1128/JB.00167-08 · DOI · Paper page
- Boles, 2011, Staphylococcal biofilm disassembly, Trends Microbiol., 19, 449, 10.1016/j.tim.2011.06.004 · DOI · Paper page
- Yoshii, 2017, Norgestimate inhibits staphylococcal biofilm formation and resensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics, NPJ Biofilms Microbiomes, 3, 18, 10.1038/s41522-017-0026-1 · DOI
- Costerton, 1999, Bacterial biofilms: A common cause of persistent infections, Science, 284, 5418, 10.1126/science.284.5418.1318 · DOI · Paper page
- Singh, 2010, Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms, J. Antimicrob. Chemother., 65, 1955, 10.1093/jac/dkq257 · DOI · Paper page
- Mu, 2014, Chitosan improves anti-biofilm efficacy of gentamicin through facilitating antibiotic penetration, Int. J. Mol. Sci., 15, 22296, 10.3390/ijms151222296 · DOI
- Barbieri, 2017, Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity, Microbiol. Res., 196, 44, 10.1016/j.micres.2016.12.003 · DOI · Paper page
- Subramani, 2017, Plant-derived antimicrobials to fight against multi-drug-resistant human pathogens, 3 Biotech, 7, 172, 10.1007/s13205-017-0848-9 · DOI · Paper page
- Luna, A., Lema-Alba, R.C., Dambolena, J.S., Zygadlo, J.A., Labaque, M.C., and Marin, R.H. (2017). Thymol as natural antioxidant additive for poultry feed: Oxidative stability improvement. Poult. Sci., 96. · DOI
- Marchese, 2016, Antibacterial and antifungal activities of thymol: A brief review of the literature, Food Chem., 210, 402, 10.1016/j.foodchem.2016.04.111 · DOI · Paper page
- Zhou, 2019, Thymol mediates bactericidal activity against Staphylococcus aureus by targeting an aldo-keto reductase and consequent depletion of NADPH, J Agric. Food Chem., 67, 8382, 10.1021/acs.jafc.9b03517 · DOI
- Yuan, 2018, Antibacterial mechanism of thymol on methicillin-resistant Staphylococcus aureus (MRSA), J. South. China Agric. Univ., 6, 18
- McCarthy, 2015, Methicillin resistance and the biofilm phenotype in Staphylococcus aureus, Front. Cell. Infect. Microbiol., 5, 1, 10.3389/fcimb.2015.00001 · DOI · Paper page
- Humphreys, 2001, Staphylococcus epidermidis biofilms: Importance and implications, J. Med. Microbiol., 50, 582, 10.1099/0022-1317-50-7-582 · DOI · Paper page
- Nethercott, 2013, Molecular characterization of endocarditis-associated Staphylococcus Aureus, J. Clin. Microbiol., 51, 2131, 10.1128/JCM.00651-13 · DOI
- Xiang, 2017, Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development, Appl. Microbiol. Biotechnol., 101, 6671, 10.1007/s00253-017-8403-5 · DOI
- Chen, Y., Liu, T., Wang, K., Hou, C., Cai, S., Huang, Y., Du, Z., Huang, H., Kong, J., and Chen, Y. (2016). Baicalein inhibits Staphylococcus aureus biofilm formation and the quorum sensing system in vitro. PLoS ONE, 11. · DOI · Paper page
- Garrett, 2008, Bacterial adhesion and biofilms on surfaces, Prog. Nat. Sci., 18, 1049, 10.1016/j.pnsc.2008.04.001 · DOI · Paper page
- Figueiredo, 2017, The role of biofilms in persistent infections and factors involved in ica-independent biofilm development and gene regulation in Staphylococcus aureus, Crit. Rev. Microbiol., 43, 602, 10.1080/1040841X.2017.1282941 · DOI
- Joo, 2012, Molecular basis of in vivo biofilm formation by bacterial pathogens, Chem. Biol., 19, 1503, 10.1016/j.chembiol.2012.10.022 · DOI · Paper page
- Cue, 2012, Genetic regulation of the intercellular adhesion locus in staphylococci, Front. Cell. Infect. Microbiol., 2, 38, 10.3389/fcimb.2012.00038 · DOI · Paper page
- Coelho, 2008, Agr RNAIII divergently regulates glucose-induced biofilm formation in clinical isolates of Staphylococcus aureus, Microbiology, 154, 3480, 10.1099/mic.0.2007/016014-0 · DOI
- Beenken, 2004, Global gene expression in Staphylococcus aureus biofilms, J. Bacteriol., 186, 4665, 10.1128/JB.186.14.4665-4684.2004 · DOI · Paper page
- Tormo, 2005, SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development, J. Bacteriol., 187, 2348, 10.1128/JB.187.7.2348-2356.2005 · DOI · Paper page
- Valle, 2003, SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus, Mol. Microbiol., 48, 1075, 10.1046/j.1365-2958.2003.03493.x · DOI · Paper page
- Speziale, 2014, Protein-based biofilm matrices in Staphylococci, Front. Cell. Infect. Microbiol., 4, 171, 10.3389/fcimb.2014.00171 · DOI · Paper page
- Houston, 2011, Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype, Infect. Immun., 79, 1153, 10.1128/IAI.00364-10 · DOI · Paper page
- Okshevsky, 2015, Extracellular DNA as a target for biofilm control, Curr. Opin. Biotechnol., 33, 73, 10.1016/j.copbio.2014.12.002 · DOI · Paper page
- Kaplan, 2012, Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci, J. Antibiot., 65, 73, 10.1038/ja.2011.113 · DOI · Paper page
- Kouidhi, 2015, Drug resistance of bacterial dental biofilm and the potential use of natural compounds as alternative for prevention and treatment, Microb. Pathog., 80, 39, 10.1016/j.micpath.2015.02.007 · DOI · Paper page
- Arciola, 2015, Biofilm-based implant infections in orthopaedics, Adv. Exp. Med. Biol., 830, 29, 10.1007/978-3-319-11038-7_2 · DOI · Paper page
- Costerton, 2005, Biofilm in implant infections: Its production and regulation, Int. J. Artif. Organ., 28, 1062, 10.1177/039139880502801103 · DOI · Paper page
- Yao, 2018, Protective effects of thymol on LPS-induced acute lung injury in mice, Microb. Pathog., 116, 8, 10.1016/j.micpath.2017.12.065 · DOI
- Xu, 2017, Intraperitoneal vancomycin plus either oral moxifloxacin or intraperitoneal ceftazidime for the treatment of peritoneal dialysis−related peritonitis: A randomized controlled pilot study, Am. J. Kidney Dis., 70, 30, 10.1053/j.ajkd.2016.11.008 · doi:10.1053/j.ajkd.2016.11.008
- Eto, D., Lao, C., DiToro, D., Barnett, B., Escobar, T.C., Kageyama, R., Yusuf, I., and Crotty, S. (2011). IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE, 6. · DOI · Paper page
- Rey, 2016, Graft-derived IL-6 amplifies proliferation and survival of effector T cells that drive alloimmune-mediated vascular rejection, Transplantation, 100, 1
- Wang, 2018, Thymol alleviates lipopolysaccharide-stimulated inflammatory response via downregulation of RhoA-mediated NF-κB signalling pathway in human peritoneal mesothelial cells, Eur. J. Pharmacol., 833, 210, 10.1016/j.ejphar.2018.06.003 · DOI
- Yuan, 2019, The antibacterial mechanism of oridonin against methicillin-resistant Staphylococcus aureus (MRSA), Pharm. Biol., 57, 710, 10.1080/13880209.2019.1674342 · DOI
- Laudadio, 2019, Natural alkaloid berberine activity against Pseudomonas aeruginosa MexXY-mediated aminoglycoside resistance: In silico and in vitro studies, J. Nat. Prod., 7, 1935, 10.1021/acs.jnatprod.9b00317 · DOI
- Brilhante, 2019, Terpinen-4-ol inhibits the growth of Sporothrix schenckii complex and exhibits synergism with antifungal agents, Future Microbiol., 14, 1221, 10.2217/fmb-2019-0146 · DOI
- Qian, 2015, Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus, Int. J. Med. Microbiol., 6, 501, 10.1016/j.ijmm.2015.05.001 · DOI
- Zhang, 2017, Chalcone attenuates Staphylococcus aureus virulence by targeting sortase A and alpha-hemolysin, Front. Microbiol., 8, 1715, 10.3389/fmicb.2017.01715 · DOI
- Sun, 2016, Pseudomonas fluorescens filamentous hemagglutinin, an iron-regulated protein, is an important virulence factor that modulates bacterial pathogenicity, Front. Microbiol., 7, 1320, 10.3389/fmicb.2016.01320 · DOI
- Saising, 2012, Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms, Antimicrob. Agents Chemother., 56, 5804, 10.1128/AAC.01296-12 · DOI
- Chan, 2011, Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase, J. Ethnopharmacol., 137, 767, 10.1016/j.jep.2011.06.039 · DOI · Paper page
- Freeman, 1989, New method for detecting slime production by coagulase negative staphylococci, J. Clin. Pathol., 42, 872, 10.1136/jcp.42.8.872 · DOI · Paper page
- Podbielska, 2010, Slime production by Staphylococcus aureus and Staphylococcus epidermidis strains isolated from patients with diabetic foot ulcers, Arch. Immunol. Exp., 58, 321, 10.1007/s00005-010-0079-9 · DOI
- Rice, 2007, The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus, Proc. Natl. Acad. Sci. USA, 104, 8113, 10.1073/pnas.0610226104 · DOI · Paper page
- Ouyang, P., He, X., Yuan, Z.W., Yin, Z.Q., Fu, H., Lin, J., He, C., Liang, X., Lv, C., and Shu, G. (2018). Erianin against Staphylococcus aureus Infection via Inhibiting Sortase A. Toxins, 10. · DOI
- Thomas, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat. Protoc., 3, 1101, 10.1038/nprot.2008.73 · DOI · Paper page
- Christensen, 2012, Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model, J. Antimicrob. Chemother., 67, 1198, 10.1093/jac/dks002 · DOI · Paper page
- Luo, J., Dong, B., Wang, K., Cai, S., Liu, T., Cheng, X., Lei, D., Chen, Y., Li, Y., and Kong, J. (2017). Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model. PLoS ONE, 12. · DOI · Paper page
- Inoue, 2017, Inhibition of biofilm formation on iodine-supported titanium implants, Methods Int. Orthop., 41, 1093, 10.1007/s00264-017-3477-3 · doi:10.1007/s00264-017-3477-3
- Feldman, 2014, Tissue processing and hematoxylin and eosin staining, Methods Mol. Biol., 1180, 31, 10.1007/978-1-4939-1050-2_3 · DOI · Paper page
Cited by
Thymol and Thyme Essential Oil—New Insights into Selected Therapeutic Applications
Kowalczyk, A., Przychodna, M., Sopata, S., Bodalska, A., & Fecka, I. (2020) · Molecules · doi:10.3390/molecules25184125 · Cited by 480
Garcia-Salinas, S., Gámez, E., Landa, G., Arruebo, M., Irusta, S., & Mendoza, G. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c17043 · Cited by 19
Metadata
- Authors
- Yuan, Z., Dai, Y., Ouyang, P., Rehman, T., Hussain, S., Zhang, T., Yin, Z., Fu, H., Lin, J., He, C., Lv, C., Liang, X., Shu, G., Song, X., Li, L., Zou, Y., & Yin, L.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2020-01-10
- Volume
- 8
- Issue
- 1
- Pages
- 99
- ISSN
- 2076-2607
- Cited by
- 68
- References
- 1
- Language
- en
- Funders
- National Natural Science Foundation of China (31702284)
- Double subject construction plan of Sichuan Agriculture University (03571444)
- Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System (CARS-SVDIP)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.